Author: GlobeNewswire

Take the Deep Dive in a Virtual Fireside Chat to be Held in Q1 2023YONKERS, N.Y., Dec. 19, 2022 (GLOBE…

PHILADELPHIA, Dec. 19, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC),…

Acquisition Expands The Company’s Commercial Portfolio With An Established U.S. Marketed Product Company Remains Dedicated To Growth Within Neurology Through…

DUBLIN, Ireland, Dec. 19, 2022 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to…

New leaders to elevate product portfolio, customer-centric commercial capabilities, and sales and marketing execution SALT LAKE CITY, Dec. 19, 2022…

WESTMINSTER, Colo., Dec. 19, 2022 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that James Flynn has joined…

NAARDEN, the Netherlands and MIAMI, Dec. 19, 2022 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq:NAMS or “NewAmsterdam” or the…

LONDON and RALEIGH, N.C., Dec. 19, 2022 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”),…

BNC210 for Treatment of Social Anxiety Disorder (SAD) Did Not Meet Primary EndpointSubjects with Confirmed SAD who Received BNC210 Exhibited…

CONSHOHOCKEN, Pa., Dec. 18, 2022 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics…